🕵️ Pulse Biosciences, Inc. ($PLSE)
SEC insider & ownership activity, last 12 months · CIK 1625101 · every row links its SEC filing
Over the last 12 months insiders sold $5.2M against $16.1M of open-market buying. Robert W. Duggan bought $15.8M (Sep–May). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $16.1M (5 lots) · 2 sellers, $5.2M (15 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Robert W. Duggan | 4 | $15.8M | 0 | – | May 11, 2026 |
| Kevin Danahy | 0 | – | 10 | $3.4M | Feb 18, 2026 |
| Darrin Uecker | 0 | – | 5 | $1.9M | Sep 17, 2025 |
| Paul A. Laviolette | 1 | $295K | 0 | – | May 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Robert W. Duggan | 71.9% | 13D | May 11, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Kevin Danahy | $1.3M | Feb 12, 2026 | filing ↗ |
| Kevin Danahy | $1.6M | Feb 9, 2026 | filing ↗ |
| Kevin Danahy | $407K | Sep 18, 2025 | filing ↗ |
| Darrin Uecker | $1.8M | Sep 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | May 5, 2026 | filing ↗ |
| Earnings (2.02) | May 4, 2026 | filing ↗ |
| Other events (8.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 8, 2026 | filing ↗ |
| Other events (8.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Other events (8.01) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 27, 2026 | filing ↗ |